Taken together, these observations suggest that TGF-β treatment, leads to significant remodeling of the plasma membrane and ECM proteins, by inducing the CF activation pathways, where once again convergent responses were observed for the three different CF sources evaluated. Here, TGFB1 is linked to cystic fibrosis.